BioSpace News Archive

Business

VistaGen Therapeutics to Report 2021 Fiscal Year End Financial Results, Provide a Business Update and Host Conference Call and Webcast June 29, 2021

VistaGen Therapeutics, Inc . today announced that it will host a corporate update conference call on Tuesday, June 29, 2021 at 2:00 pm Pacific Time (5:00 pm Eastern Time) to discuss its financial and operating results for fiscal year ended March 31, 2021.

June 25, 2021
·
1 min read
Biotech Beach

BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®Chairman Terren Peizer discusses BioVie’s late-stage drug pipeline with multiple shots on goal

BioVie Inc. today announced an interview with Terren Peizer, Chairman, that will air on The RedChip Money Report ® on the Bloomberg Network in the U.S. on this coming Saturday, June 26th, at 7 p.m. local time in 73 million homes across the United States.

June 25, 2021
·
3 min read
Business

Reminder: Centene Corporation’s 2021 Second Quarter Financial Results Conference Call

Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2021 second quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday , July 27, 2021, and host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results.

June 25, 2021
·
2 min read
Business

Cancer Research Institute (CRI) Launches Spanish-Language Resource Hub In Its Commitment To Lead The Change In Racial Health Equity

The Cancer Research Institute announced that is has launched its first-ever Spanish-language information hub to connect Hispanic patients and caregivers with the latest cancer immunotherapy research and treatment options.

June 25, 2021
·
4 min read
Drug Development

I-Mab Announces China NMPA Approval for Phase 1b Trial of Felzartamab in Systemic Lupus Erythematosus

I-Mab today announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application to initiate a phase 1b trial of felzartamab, a CD38 antibody, in patients with systemic lupus erythematosus (SLE).

June 25, 2021
·
5 min read
Happiness Biotech Announces $2.16 Million Registered Direct Offering To Strategic Investors

Happiness Biotech Group Limited announced today that it has entered into a securities purchase agreement with certain non-U.S. strategic investors for a registered direct placement of approximately $2.16 million.

June 25, 2021
·
4 min read
Deals

Acurx Pharmaceuticals, Inc. announces pricing of $15 Million underwritten Initial public offering of common stock

Acurx Pharmaceuticals, Inc. today announced the pricing of an underwritten initial public offering of 2,500,000 newly-issued shares of its common stock at a price of $6.00 per share.

June 25, 2021
·
3 min read
Business

Slayback Appoints Pete Meyers as Chief Financial Officer

Slayback Pharma LLC announced today the appointment of Pete A. Meyers as its Chief Financial Officer.

June 25, 2021
·
2 min read
Policy

Sanofi: Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expression

The European Commission has approved Sanofi and Regeneron’s PD-1 inhibitor Libtayo® for the first-line treatment of adults with non-small cell lung cancer whose tumor cells have ≥50% PD-L1 expression and no EGFR, ALK or ROS1 aberrations.

June 25, 2021
·
15 min read
Medication Dispenser Market: Overview, Trends, Opportunities & Competitive Landscape

The demand within the global market for medication dispenser has been rising on account of several key developments in the field of healthcare.

June 25, 2021
·
4 min read